Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
care medicine. We invite physicians with interest or expertise in cystic fibrosis or pulmonary hypertension to apply. Passion for teaching and mentorship. Contact Dr. Ruxana Sadikot, Chief, Division
-
Summary: Our lab aims to understand the mechanisms underlying metabolic remodeling and cardiac fibrosis in hypertrophic cardiomyopathy (HCM), using mouse models and human induced pluripotent stem cells
-
is looking for a postdoctoral associate to explore the role of age associated metabolic perturbations in epithelial progenitors during the development of progressive lung fibrosis. The lab uses a
-
feature nationally recognized programs and leaders in Interstitial Lung Disease, COPD, Lung Transplantation, Critical Care Medicine (Respiratory Failure & ARDS), Cystic Fibrosis, Interventional Pulmonary
-
biology/pluripotent stem cells Metabolism Inflammation and autoimmunity Tissue remodeling and fibrosis Cardiac/Vascular biology Recruited faculty will have opportunities to collaborate with other faculty in
-
: Medicine, Cardiovascular Medicine Postdoc Appointment Term: One year (with option to reappoint) Appointment Start Date: As soon as possible Group or Departmental Website: https://ashleylab.stanford.edu/(link
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 2 months ago
-obstructive diseases and fibrosis therapeutic development, two areas of urgent clinical need. Multiple therapeutic modalities will be evaluated for target engagement, molecular mechanisms and therapeutic
-
fibrosis and inflammation create a microenvironment which inhibits axonal regeneration, resulting in poor neurologic recovery. To overcome this gap from bench to clinic, we have developed a basic science